Viz HCM vs Aorta-CAD
AI Verdict
Choose Viz HCM if…
Choose Viz HCM if your institution prioritizes real-time, AI-powered detection of suspected Hypertrophic Cardiomyopathy (HCM) directly from ECGs to significantly reduce diagnosis time. This tool is ideal for rapidly coordinating multidisciplinary cardiac care teams and automating patient pathways for a specific, critical cardiac condition.
View Viz HCM →Choose Aorta-CAD if…
Choose Aorta-CAD if your practice or radiology department seeks to enhance the detection of Aortic Atherosclerosis and Aortic Ectasia on routine chest X-rays. This cloud-based AI solution seamlessly integrates into existing X-ray reading workflows, providing an assistive overlay to improve diagnostic accuracy for these aortic conditions.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz HCM | Aorta-CAD |
|---|---|---|
| Deployment | Unknown | Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM offers mobile-based alerts and automated patient direction for multidisciplinary care teams, suggesting a more active and integrated role in the care pathway. While Aorta-CAD provides seamless integration and a toggleable overlay for diagnostic assistance, Viz HCM's features indicate a broader impact on workflow and team communication.
Clinical Value
Viz HCMBoth tools are FDA-cleared and demonstrate clinical benefits. Viz HCM focuses on significantly reducing diagnosis time and coordinating care for Hypertrophic Cardiomyopathy, a complex and often missed disease, backed by extensive real-world evidence. This comprehensive approach to care coordination adds a layer of value beyond Aorta-CAD's demonstrated reduction in detection misses.
Pricing & Value
Viz HCMViz HCM provides greater transparency by detailing its subscription-based pricing and explicitly mentioning CMS reimbursement availability for specific CPT codes with a national payment rate. Aorta-CAD only states 'contact for pricing,' making it difficult to assess its immediate value proposition without direct vendor engagement.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being cloud-based, FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAA). Viz HCM explicitly mentions integration with EHR and PACS, while Aorta-CAD emphasizes seamless integration into existing X-ray reading workflows. Both are well-equipped for deployment in healthcare enterprises.
Innovation
Viz HCMViz HCM exhibits a higher degree of innovation by combining real-time AI-powered ECG analysis for HCM detection with automated, mobile-based alerts and patient direction for multidisciplinary care teams. This extends beyond diagnostic assistance to actively transforming the patient care pathway and coordination.
Support & Docs
Viz HCMViz.ai offers a comprehensive 'Customer Support' section, a 'Knowledge Base,' and a 'dedicated customer success team' comprising Clinical and Workflow Specialists, Customer Success Managers, and Clinical Research Scientists. This structured approach to ongoing support, training, and education provides a slight edge over Imagen Technologies' direct 24/7 emergency support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz HCM | Aorta-CAD |
|---|---|---|
| Tool Name | Viz HCM | Aorta-CAD |
| Company | Viz.ai | Imagen Technologies |
| Description | Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. | Aorta-CAD by Imagen Technologies is an FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows. |
| Target Condition(s) | Hypertrophic Cardiomyopathy (HCM) | Aortic Atherosclerosis and Aortic Ectasia |
| Modality | Real-time ECG analysis | Chest X-rays |
| Key Features | AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection; Real-time disease detection from electrocardiograms; Mobile-based alerts and notifications to multidisciplinary care teams; Automated direction of patients to appropriate care specialists; Reduces time to diagnosis and treatment for HCM; Streamlines cardiac care coordination and clinical workflows; Seamless integration with existing clinical workflows, EHR, and PACS systems; Clinically validated with extensive real-world evidence and publications. | Detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia; Cloud-based, software-only medical device; Utilizes deep learning algorithms for analysis; Seamlessly integrates into existing X-ray reading workflows; Creates annotations via an overlay that can be toggled on/off; Assists physicians (radiologists and PCPs) in interpreting chest X-rays; Demonstrated 62% relative reduction in misses for aortic calcification in clinical study; Demonstrated 35% relative reduction in misses for dilated aorta in clinical study. |
| Specialties | Cardiology, Emergency Medicine, Hospital Medicine | Cardiology, Internal Medicine, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Viz HCM and Aorta-CAD.